How would this work to Bayer's advantage if marketing was suspended? Although Trayslol was no longer being shipped last December, remaining inventories in hospitals can still be used by doctors. By talking up the drug's usefulness, however, Bayer may create cries for demand, which may eventually help convince regulators to allow the product to become available again, perhaps sooner than later. Clever, yes?
Discuss   Add this link to...  Bury

Comments Who Voted Related Links